Facebook Twitter Instagram
    Trending
    • Unraveling The Activities Of Hindenburg Research: A Notorious Corporate Mafia Out To Ruin Unsuspecting Corporations
    • Rishi Sunak And Joe Biden Announce Green Funding Agreement
    • Facebook Owner Meta Plans To Create Twitter Rival
    • Canada Wildfires: Global Help Arrives As Quebec Fights Fires
    • Census 2023: Postponement Was To Avert National Crisis, Says NPC
    • Mike Pence Tears Into Donald Trump At 2024 Campaign Launch
    • Heathrow Security Officers Announce Summer Strikes
    • National Assembly: Tinubu, APC Move To Appease Anti-Zoning Members
    Facebook Twitter Instagram YouTube
    Sync News NigSync News Nig
    • NEWS
      • Business & Economy
      • Politics
      • Banking & Finance
      • Tech & Innovation
      • Health
      • World
    • BRAND NEWS
    • SPORT
      • Football
      • Boxing
      • Basketball
    • ENTERTAINMENT
      • Celebrities
      • Music
      • Movies
    • FEATURED
    • TRAVELS & LIFESTYLE
      • Beauty &Health
      • Fashion
      • Food, Travel, Arts & Culture
      • Relationships & Weddings
    • SYNC TV
    Sync News NigSync News Nig
    Home»News»World»Abortion Pill Under Threat In US
    World

    Abortion Pill Under Threat In US

    Bolanle Oduekun-AyoolaBy Bolanle Oduekun-AyoolaMarch 15, 2023Updated:March 15, 2023No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The United States abortion opponents are hoping for a national ban on a widely used abortion pill when their lawsuit against government drug regulators is argued Wednesday in the Texas court of a deeply conservative judge believed to be sympathetic to their cause.

    Galvanized after the US Supreme Court ended the nationwide right to abortion last June, anti-abortion forces are now targeting the prescription drug mifepristone in their campaign to win a total ban on the practice.

    The suit against the US Food and Drug Administration (FDA) aims at a pill involved in 53 percent of all abortions in the United States, or more than a half-million every year.

    While the FDA has never been challenged like this before on its approval of a drug that has proven safe and effective, the plaintiffs, a coalition of anti-abortion groups, believe they can win a national freeze on distribution of mifepristone.

    Presiding over the case in federal court in Amarillo, Texas will be Judge Matthew Kacsmaryk, a deeply conservative Christian with a personal history of opposition to abortion and a court record of favoring right-wing causes.

    The case ended up in his court via what critics call “judge-shopping,” in which plaintiffs take legal action in a district where the judge has a history of rulings that support their case.

    – Record of safety –

    One component of a two-drug regimen used for medication abortion, mifepristone can be used in the United States up to 10 weeks of pregnancy.

    It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.

    But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying the approval of mifepristone “disavow(ed)” science, “ignored” potential health impacts and “disregarded” the complications that can arise with its use.

    “The FDA failed America’s women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States,” they said.

    The FDA has urged the judge to reject the request.

    “The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years,” it said.

    – Already banned in some states –

    Currently, some 15 states have laws restricting access to mifepristone by requiring a physician provide it, according to the Guttmacher Institute, a reproductive health policy and research group. Abortion care has halted in another 13 states after the Supreme Court overturned the long-established constitutional right last June.

    The Texas suit seeks to block mifepristone nationally by overturning the FDA’s approval of the drug, and asks Kacsmaryk to first suspend the approval via injunction — an effective ban — while the lawsuit proceeds through his court.

    Abortion rights groups say a ruling blocking mifepristone would be as earth-shaking as the Supreme Court’s ruling last year.

    “Access to medication abortion would end across the country — even in those states where abortion rights are protected,” the Center for Reproductive Rights said.

    If Kacsmaryk does rule for a temporary ban on mifepristone, the FDA would likely immediately appeal it, on the basis of the drug’s history and its own authority to regulate pharmaceuticals.

    But abortion rights advocates were preparing for the worst.

    “It seems unbelievable that a lone judge in Texas could make a ruling that would impact a product that has been FDA approved and safely marketed for more than two decades,” said Elisa Wells, co-founder of Plan C, which helps people access medical abortions.

    AFP

    United States of America (U.S.A)
    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Bolanle Oduekun-Ayoola

    Related Posts

    Rishi Sunak And Joe Biden Announce Green Funding Agreement

    June 9, 2023

    Canada Wildfires: Global Help Arrives As Quebec Fights Fires

    June 9, 2023

    Mike Pence Tears Into Donald Trump At 2024 Campaign Launch

    June 8, 2023

    Leave A Reply Cancel Reply

    Recent Posts
    • Unraveling The Activities Of Hindenburg Research: A Notorious Corporate Mafia Out To Ruin Unsuspecting Corporations
    • Rishi Sunak And Joe Biden Announce Green Funding Agreement
    • Facebook Owner Meta Plans To Create Twitter Rival
    • Canada Wildfires: Global Help Arrives As Quebec Fights Fires
    • Census 2023: Postponement Was To Avert National Crisis, Says NPC
    Recent Comments
    • Exceptional Keto Diet on Airtel Partners Standard Chartered Bank To Expand Fintech Business
    • Keto Genics BHB on Airtel Partners Standard Chartered Bank To Expand Fintech Business
    • Exceptional Keto Diet on Airtel Partners Standard Chartered Bank To Expand Fintech Business
    • www.ortovivaistica.it on President Buhari Extends Eased COVID-19 Lockdown By Four Weeks
    • Total Perk Keto Reviews on Airtel Partners Standard Chartered Bank To Expand Fintech Business
    Archives
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • March 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • December 2018
    Meta
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Facebook-f Twitter Instagram
    • Banking & Finance
    • Business & Economy
    • Health
    • Politics
    • World
    • Tech & Innovation

    Copyright ©, 2020-2021 syncnewsng.com. All Rights Reserved